Trial intelligence / Profile preview

Effectiveness of Smoke-Break Nicotine Delivery Device

NCT00715871Phase 2Completed

Sponsor
SmokeBreak
Start
Feb 2008
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nicotine in nicotine dependence, sponsored by SmokeBreak. Started Feb 2008; status: completed.

02

Drugs

nicotine
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT00715871.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00715871.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call